13 years 🥳 of Publication, 100k+ Stories, 30+ Countries
Search
Legal Desire
3139
Latham & Watkins Advises Coherus BioSciences in Divestment of Ophthalmology Franchise to Sandoz
Coherus BioSciences, Inc. (NASDAQ: CHRS) has announced that it has entered into an agreement to divest its CIMERLI® (ranibizumab-eqrn) ophthalmology…
Latham & Watkins Advises BridgeBio Pharma in US$1.25 Billion Cross-Border Funding
BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio or the Company), a commercial-stage biopharmaceutical focused on genetic diseases and cancers, has announced…
Latham & Watkins Advises on Winnebago Industries Inc.’s US$300 Million Offering of Convertible Senior Notes
Winnebago Industries, Inc. (NYSE: WGO), a leading North American manufacturer of outdoor lifestyle products, priced US$300 million aggregate principal amount…
Latham & Watkins Advises Yellow Wood Partners on Acquisition of Elida Beauty from Unilever
Latham & Watkins has advised Yellow Wood Partners LLC, a Boston-based private equity firm focused on investing in consumer brands…
Latham Advises EMZ Partners and H&Z on Acquisition of Transform8
Latham & Watkins has advised European private equity firm EMZ Partners (EMZ) and its portfolio company H&Z Unternehmensberatung (H&Z), a…
Linklaters advises Mediahuis on the acquisition of the remaining 30 per cent stake in Medienhaus Aachen GmbH from Rheinische Post Mediengruppe
Linklaters has advised Mediahuis on the acquisition of the remaining 30 per cent of the shares in the German publishing…
